Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:1139-1140 (24 May), doi:10.1136/bmj.39538.469421.80 (published 17 April 2008)
May not be clinically beneficial or cost effective and may reduce quality of life
| The first 150 words of the full text of this article appear below. |
In the accompanying papers, OKane and colleagues report a randomised controlled trial of blood glucose self monitoring in people with newly diagnosed diabetes (ESMON trial) and Simon and colleagues report a cost effectiveness analysis that ran alongside the previously published blood glucose self monitoring in type 2 diabetes (DiGEM) trial.1 2 3
The question of whether people with type 2 diabetes who do not use insulin should monitor their own blood glucose has been the subject of some lively exchanges in the BMJ for more than 10 years. In 1997, Marilyn Gallichan wrote, "The inappropriate use of self monitoring of glucose is wasteful of NHS resources and can cause psychological harm. There is no convincing evidence that self monitoring improves glycaemic control, nor that blood testing is necessarily better than urine testing."4 These challenging observations were disputed by correspondents who suggested that self monitoring might help people with diabetes improve blood glucose
Martin Gulliford, professor of public health
1 Department of Public Health Sciences, Kings College London, London SE1 3QD
martin.gulliford@kcl.ac.uk
Read all Rapid Responses